000			02857nam a22002897a 4500
001			C.000201
003			OSt
005			20240305193438.0
008			220712b |||||||| |||| 00| 0 eng d
020			_a020309283X
020			_a 9780203092835
040			_cDLC
082			_a 616.8918 TAY
100			_aDavid Taylor _939768
222			_aacute adverse effects alcohol Amisulpride antidepressants antipsychotic drugs Arch Gen Psychiatry aripiprazole associated atypical antipsychotics behaviour benzodiazepines Biol Psychiatry bipolar depression bipolar disorder buprenorphine bupropion carbamazepine cardiac Child Adolesc children and adolescents citalopram Clin Psychiatry clinical clozapine clozapine-induced Cochrane Database Syst cognitive controlled trial Database Syst Rev dementia diabetes discontinuation disease donepezil dose double-blind efficacy excreted fluoxetine haloperidol hepatic increased interactions lamotrigine lithium major depressive mania medication meta-analysis metabolism methadone methylphenidate mg/day mirtazapine monitoring neuroleptic Neuropsychopharmacol olanzapine open-label opioid oral overdose paroxetine patients with schizophrenia pharmacokinetics placebo placebo-controlled study placebo-controlled trial plasma levels pregnancy prescribed Psychiatry Psychiatry 1999 Psychiatry 2006 Psychopharmacol 2008 psychosis psychotic psychotropic quetiapine randomised randomized recommended reduced relapse renal impairment reported risk risperidone Schizophr schizophrenia seizures serotonin reuptake inhibitors sertraline serum side effects SSRIs switching symptoms syndrome tardive dyskinesia therapy tolerated toxicity treated treatment treatment-resistant valproate venlafaxine weeks weight gain ziprasidone
245			_aThe Maudsley Prescribing Guidelines
250			_a 10th edition, revised
260			_aBoca Raton _bCRC Press _c2009
300			_a544 pages
505			_aContents: Chapter 1 Plasma level monitoring of psychotropics and anticonvulsants Chapter 2 Schizophrenia Chapter 3 Bipolar disorder Chapter 4 Depression and anxiety Chapter 5 Children and adolescents Chapter 6 Substance misuse Chapter 7 Use of psychotropics in special patient groups Chapter 8 Miscellaneous conditions and substances Index
520			_aOne of the most widely used guides to prescribing psychiatric medications, the Tenth Edition of Maudsley Prescribing Guidelines returns with fully updated content and new sections on the latest topics of interest in the field of psychiatry. A must-have reference for prescribers, nursing staff, pharmacists, family physicians, and other professions
600			_x Medical / Psychiatry / General _926946
600			_xMedical / General _926821
600			_x Medical › Psychiatry › General _926951
700			_aCarol Paton _939769
942			_2ddc _cBK
999			_c18144 _d18144